Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Engagement of Patients With Advanced Cancer [NA]
Clinical trial update noting engagement of patients with advanced cancer; status completed and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma [EARLY_Phase 1]
An early-phase neoadjuvant study evaluating the immunogenicity and biomarker signals of ipilimumab in melanoma patients.
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Moletest Clinical Study in Scotland
Moletest Scotland Ltd conducted a clinical trial for melanoma in Scotland that has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP) [Phase 1]
A Phase 1 trial sponsored by Rockefeller University evaluating diphenylcyclopropenone for cutaneous metastases of melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma [Phase 1]
Phase 1 trial update of NPI-0052 (marizomib) and vorinostat in patients with non-small cell lung cancer, pancreatic cancer, melanoma, lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma [Phase 3]
Phase 3 trial evaluating Aldesleukin with or without vaccine therapy in locally advanced or metastatic melanoma has completed, and the resul…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma [Phase 1]
A Phase 1 trial evaluating dabrafenib with or without trametinib in combination with ipilimumab for patients with V600E/K mutation‑positive …
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating RO4929097 (gamma-secretase/Notch pathway inhibitor) with cisplatin, vinblastine, and temozolomide in recurrent or…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma [Phase 1, Phase 2]
This trial update reports results from a Phase 1/2 study evaluating ipilimumab with or without talimogene laherparepvec (T-VEC) in patients …
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067) [Phase 3]
Phase 3 CheckMate 067 in previously untreated advanced melanoma compared nivolumab alone or with ipilimumab against ipilimumab alone. Result…
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial update for immunotherapy using 41BB-selected tumor infiltrating lymphocytes in metastatic melanoma; study terminated with post…
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients [Phase 2]
Phase 2 trial update comparing pembrolizumab with dual MAPK pathway inhibition plus pembrolizumab in metastatic melanoma is reported as ongo…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Multiple Antigen-Engineered DC Vaccine for Melanoma [Phase 1]
A Phase 1 trial evaluating a multiple antigen-engineered dendritic cell vaccine for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma [Phase 1]
Phase I study evaluating endovenous administration of the oncolytic adenovirus ICOVIR-5 in patients with locally advanced or metastatic mela…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Study of a DNA Immunotherapy to Treat Melanoma [Phase 1, Phase 2]
The Phase 1/Phase 2 clinical trial of a DNA immunotherapy for malignant melanoma sponsored by Scancell Ltd has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma [Phase 1]
A Phase I trial of a humanized anti-GD2 antibody in children and adolescents with neuroblastoma, osteosarcoma, Ewing sarcoma, and melanoma h…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer [Phase 1]
This Phase 1 trial update reports results for a NY-ESO-1 vaccine with the GLA-SE adjuvant in patients with unresectable or metastatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma [Phase 2]
Phase 2 biomarker-enriched study of TH-302 (evofosfamide) in subjects with advanced/metastatic melanoma was terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Dendritic Cells (DC) Vaccine for Metastatic Melanoma [Phase 2]
Phase 2 clinical trial update on a dendritic cell vaccine for metastatic melanoma; the study was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: Pilot Study of IFN α2b for Melanoma Patients [EARLY_Phase 1]
A Phase 1 pilot trial of interferon alfa-2b in melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma [Phase 2]
Phase 2 study of ipilimumab in children and adolescents with unresectable or metastatic malignant melanoma was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma [Phase 2]
Phase 2 trial update showing anti-tumor activity of SB-485232 in patients with previously untreated metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
This Clinical Trial Update reports the completion of a study on the culture and characterization of circulating tumor cells (CTCs) in melano…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation [Phase 2]
Phase 2 study evaluating pulsatile LGX818 (encorafenib) in BRAFV600-mutant melanoma (stage IV or unresectable stage III) completed with resu…